Global Ectopic Pregnancy Market, By Type (Tubal Pregnancy, Non- Tubal Ectopic Pregnancy, Heterotopic Pregnancy), Treatment (Corticosteroid, Folic Acid Analogue), Route of Administration (Oral, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2029.
Ectopic Pregnancy Market Analysis and Size
The global ectopic pregnancy market is expected to witness significant growth during the forecast period. Around 1 in every 50 pregnancies in the U.S. is an ectopic pregnancy. The likelihood of having an ectopic pregnancy can be lower or higher than the average as several health factors increase or lower one’s personal risk. Ectopic pregnancy can be treated in three ways: expectant management, medication and surgical method.
Data Bridge Market Research analyses a growth rate in the global ectopic pregnancy market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Ectopic Pregnancy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Tubal Pregnancy, Non- Tubal Ectopic Pregnancy, Heterotopic Pregnancy), Treatment (Corticosteroid, Folic Acid Analogue), Route of Administration (Oral, Parenteral), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Hikma Pharmaceuticals PLC (U.K.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Accord Healthcare, Inc. (U.S.), Eli Lilly and Company (U.S.), Sanofi (France), Bayer AG (Germany), Amgen Inc (U.S.), Zhejiang Davi Pharmaceutical Co., Ltd (China), Samex Overseas (India), FARMHISPANIA GROUP (Spain), Hubei Haosun Pharmaceutical Co., Ltd (China), Stason Pharmaceuticals (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Ectopic pregnancy occurs when a fertilized egg implants itself outside of the womb, generally, implantation reported in one of the fallopian tube. The implantation of egg in one of the fallopian tubes impedes the process of egg conversion in to baby. Furthermore, it poses health risk to pregnant women. Symptoms includes missed pregnancy, tummy pain, vaginal bleeding, and pain in tip of the shoulder. The medication generally prescribed for treatment of ectopic pregnancy is methotrexate among others.
Global Ectopic Pregnancy Market Dynamics
Drivers
- Growing maternity care
Rising maternity care concerns among people, increasing influence of product advertising through social media campaigns about pregnancy care products, several organic during pregnancy, rising reimbursement on pregnancy care products globally, and increasing preference of women for commercially available popular products over home remedies for skincare and other products are some of the major trends.
- Growing investment for healthcare infrastructure
The increasing technological advancements, higher birth rates in developing as well as some developed countries, and increased R&D activities among manufacturers to develop advanced and effective pregnancy care solutions will all contribute by creating huge opportunities that will boost the growth of the ectopic pregnancy market in the forecast period of 2022-2029.
Opportunities
- Availability of different diagnostic tests
There are several diagnostic tests that are available for diagnosing ectopic pregnancy are creating much opportunities for the market growth. Tests such as visualization of an extrauterine gestational sac with a yolk sac or embryo, testing serum hCG and no products of conception on uterine aspiration with subsequent rising or plateauing hCG levels. All these factors are boosting the market growth.
- Increasing Demand for Advanced Treatments
Several women having ectopic pregnancy are treated with medication (methotrexate) rather than surgery have a lower risk of recurrent ectopic pregnancy. Another option is surgery which is widely acceptable. This creates more opportunity for the market growth.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to perform these treatments could curb the growth of the global ectopic pregnancy market over a forecast period.
- High Cost
The huge expenditure required for the surgeries and treatment processes surely hamper the market growth. Several market players make huge investment in installing new and advanced treatment procedures to faster the recovery process and in return the cost is increased.
This global ectopic pregnancy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global ectopic pregnancy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Ectopic Pregnancy Market
COVID-19 has left a major global public health crisis that has impacted practically every business. Its long-term repercussions are anticipated to influence industry growth during the forecast period.
In the post-pandemic era, COVID-19 is expected had a negative impact on the market initially as all the clinical trials and elective surgeries were postponed. In the post pandemic era, the market is slowly getting boosted as the surgeries and patient visits are increasing.
Global Ectopic Pregnancy Market Scope
The global ectopic pregnancy market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Tubal Pregnancy
- Non-Tubal Ectopic Pregnancy
- Heterotopic Pregnancy
Treatment
- Corticosteroid
- Folic Acid Analogue
Route of Administration
- Oral
- Parenteral
End User
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Ectopic Pregnancy Market Regional Analysis/Insights
The global ectopic pregnancy market is analyzed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global ectopic pregnancy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
America dominates the market in the forecast period due to increasing cases of chlamydial infections and smoking among the female population.
Asia-Pacific is considered the most lucrative period due to increasing research and developmental activities for developing novel therapies and increasing investment for developing advanced manufacturing facilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Ectopic Pregnancy Market Share Analysis
The global ectopic pregnancy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global ectopic pregnancy market.
Key players operating in the global ectopic pregnancy market include:
- Hikma Pharmaceuticals PLC (U.K.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Novartis AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Accord Healthcare, Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Sanofi (France)
- Bayer AG (Germany)
- Amgen Inc (U.S.)
- Zhejiang Davi Pharmaceutical Co., Ltd (China)
- Samex Overseas (India)
- FARMHISPANIA GROUP (Spain)
- Hubei Haosun Pharmaceutical Co.,Ltd. (China)
- Stason Pharmaceuticals (U.S.)
SKU-